CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash Flows from Operating Activities:
Net (loss) income	$ (55,572)	$ 60,750
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization (inclusive of depreciation included in cost of service)	11,893	14,228
Non-cash compensation	12,381	12,495
Amortization and impairment of operating lease right of use assets	16,971	22,463
Loss on disposal of property and equipment	356	531
Loss on personal care divestiture	2,186	0
Merger termination fee	106,000	0
Deferred income taxes	8,104	6,003
Equity in (earnings) loss from equity method investments	(8,114)	744
Amortization of deferred debt issuance costs	495	495
Return on equity method investments	2,753	2,428
Changes in operating assets and liabilities, net of impact of acquisitions:
Patient accounts receivable	7,862	(21,344)
Other current assets	1,689	(4,468)
Operating lease right of use assets	(1,937)	(1,662)
Other assets	244	220
Accounts payable	(4,731)	4,498
Accrued expenses	4,775	29,529
Other long-term obligations	(3,179)	(223)
Operating lease liabilities	(15,456)	(20,657)
Net cash provided by operating activities	86,720	106,030
Cash Flows from Investing Activities:
Proceeds from the sale of deferred compensation plan assets	25	28
Proceeds from the sale of property and equipment	100	37
Purchases of property and equipment	(2,744)	(2,782)
Investments in technology assets	(6,667)	(559)
Purchase of cost method investment	0	(15,000)
Proceeds from personal care divestiture	47,787	0
Acquisitions of businesses, net of cash acquired	(350)	(73,311)
Net cash provided by (used in) investing activities	38,151	(91,587)
Cash Flows from Financing Activities:
Proceeds from issuance of stock upon exercise of stock options	75	772
Proceeds from issuance of stock under employee stock purchase plan	1,754	1,891
Shares withheld to pay taxes on non-cash compensation	(3,488)	(4,762)
Noncontrolling interest contributions	376	952
Noncontrolling interest distributions	(712)	(975)
Proceeds from borrowings under revolving line of credit	23,000	298,500
Repayments of borrowings under revolving line of credit	(23,000)	(283,500)
Principal payments of long-term obligations	(60,993)	(6,975)
Purchase of company stock	0	(17,351)
Payment of accrued contingent consideration	(4,055)	0
Purchase of noncontrolling interest	(800)	0
Net cash used in financing activities	(67,843)	(11,448)
Net increase in cash, cash equivalents and restricted cash	57,028	2,995
Cash, cash equivalents and restricted cash at beginning of period	54,133	45,769
Cash, cash equivalents and restricted cash at end of period	111,161	48,764
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	13,031	4,489
Cash paid for income taxes, net of refunds received	15,820	22,977
Cash paid for operating lease liabilities	17,394	22,319
Cash paid for finance lease liabilities	5,321	735
Supplemental Disclosures of Non-Cash Activity:
Right of use assets obtained in exchange for operating lease liabilities	14,802	26,590
Right of use assets obtained in exchange for finance lease liabilities	27,944	1,316
Reductions to right of use assets resulting from reductions to operating lease liabilities	15,135	2,763
Reductions to right of use assets resulting from reductions to finance lease liabilities	894	0
Accrued contingent consideration	0	19,195
Noncontrolling interest contribution	$ 0	$ 8,900